Digital Insomnia (DTx) Market (2026 - 2036)
Digital Insomnia (DTx) Market Size and Share Forecast Outlook 2026 to 2036
Core Findings
Digital Insomnia (DTx) Market Forecast and Outlook 2026 to 2036
The global digital insomnia (DTx) market is projected to grow from USD 513.0 million in 2026 to USD 3,747.3 million by 2036, reflecting a 22% CAGR.
Digital Insomnia (DTx) Market Key Takeaways
- Digital Insomnia (DTx) Market Value (2026): USD 513.0 million
- Digital Insomnia (DTx) Market Forecast Value (2036): USD 3,747.3 million
- Digital Insomnia (DTx) Market Forecast CAGR: 22.0%
- Leading Type in Digital Insomnia (DTx) Market: CBT-I digital therapeutics (prescription or regulated)
- Key Growth Regions in Digital Insomnia (DTx) Market: North America, Europe, Asia Pacific, Latin America, Middle East & Africa
- Top Players in Digital Insomnia (DTx) Market: Big Health Ltd., Teladoc Health, Happify Health, ResMed Inc.
-market-market-value-analysis.webp)
This trajectory reflects a shift from discovery-led pilots to an industrial-scale operating model built on repeatable delivery. Product release management, clinical evidence packages, onboarding flows, and update governance now follow standardized frameworks that allow predictable rollout across large populations.
In this category, manufacturing is expressed through software production discipline, capacity planning, security controls, and support operations that scale without service variation. Supply chain resilience takes the form of multi-region hosting, redundancy in data services, and stable content pipelines, which lowers operational risk for institutions. These changes reduce adoption friction for hospitals, insurers, and employer programs by simplifying integration, contracting, and lifecycle management. The expansion should be read as a durable migration of volume into this care pathway, not a transient cycle of experimentation.
Digital Insomnia (DTx) Market
| Metric | Value |
|---|---|
| Market Value (2026) | USD 513 million |
| Forecast Value (2036) | USD 3,747.3 million |
| Forecast CAGR (2026-2036) | 22% |
Category
| Category | Segments |
|---|---|
| DTx Product Types | CBT-I digital therapeutics (prescription or regulated); CBT-I consumer apps (non-prescription); Sleep coaching and tele-psychology bundles; Comorbidity modules (anxiety, pain, menopause); Data integrations and outcomes reporting |
| Use Cases | Chronic insomnia disorder treatment; Insomnia with anxiety or depression overlap; Insomnia in cardiometabolic patients; Shift-work or occupational insomnia; Post-acute or post-COVID sleep support |
| End User or Channel | Payers or employers (benefit programs); Provider-prescribed DTx channel; Direct-to-consumer subscriptions; Telehealth platforms; Others |
| Region | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
Digital Insomnia (DTx) Market Segmental Analysis
Why Do Regulated CBT-I Digital Therapeutics Hold the Leading Product Share in The Digital Insomnia Market?
-market-analysis-by-dtx-product-types.webp)
Regulated CBT-I digital therapeutics hold the leading product share at 50% and sit inside institutional care rather than lifestyle spending. Employers and payers face productivity loss, repeat visits, and uneven access across legacy pathways. Coverage decisions place these programs inside benefits, referrals, and outcomes reporting. Daily routines integrate sessions like prescribed courses, sustaining adherence and contract value. Procurement shifts from app budgets to care budgets, turning usage into an operating line item. End users treat the service as functional infrastructure that stabilizes workdays and mood. The value centers on reliability, continuity, and predictable outcomes across long treatment cycles.
Why Does Chronic Insomnia Disorder Treatment Anchor the Largest Share of Market Demand?
-market-analysis-by-use-cases.webp)
Chronic insomnia disorder treatment holds the leading use case share at 58% and reflects a structural burden population rather than situational demand. This group generates long cycles of care, repeated consultations, and sustained productivity loss across workforces. Budget ownership sits with payers, employers, and health systems that track ongoing impact, not with discretionary wellness spending. Programs focus on continuity, documentation, and outcomes tracking over time. For the end user, this is not cosmetic improvement or optimization. It is functional life stability tied to daily performance and reliability. Acute sleep issues remain optional. Persistent conditions create non optional, recurring demand that concentrates volume and spending here.
What are the Drivers, Restraints, and Key Trends of the Digital Insomnia (DTx) Market?
- Drivers: Clinical demand for non-pharmacologic interventions that support sleep regulation, increased clinician and patient acceptance of digital therapeutics for behavioral and cognitive approaches, and payer interest in scalable, remote care solutions are shaping deployment of DTx for insomnia management.
- Restraint: Variability in clinical evidence quality across platforms, uneven reimbursement policies for digital therapeutics, and cautious clinician integration slow adoption outside specialized sleep and behavioral clinics.
- Trend 1: Expansion of programs that combine cognitive behavioral therapy for insomnia (CBT-I) frameworks with automated tracking and personalized feedback to improve adherence and outcomes.
- Trend 2: Greater integration of wearable and mobile sensor data to refine intervention timing, sleep pattern analysis, and behavioral adjustment recommendations.
Analysis of the Digital Insomnia (DTx) Market by Key Country
-market-cagr-analysis-by-country.webp)
| Country | CAGR (2026-2036) |
|---|---|
| USA | 21.5% |
| China | 24.5% |
| India | 23.0% |
| Germany | 20.0% |
| France | 17.0% |
| UK | 15.5% |
| Brazil | 14.0% |
The report covers an in-depth analysis of 40+ countries; top-performing countries are highlighted below.
How Is the Digital Insomnia (DTx) Market in the United States Shaped by Clinical Adoption Economics?
The United States shows a 21.5% annual expansion rate for digital insomnia therapeutics through 2036, driven by reimbursement mechanics and provider workflow integration. Large health systems treat insomnia inside standardized care pathways that link screening, prescription, monitoring, and outcome reporting. Digital therapeutics fit this structure because deployment does not require physical capacity expansion. Payers accept these tools when cost offsets appear in medication use and visit frequency. Employer health programs add another demand layer through population level sleep management. Growth follows the pace at which hospital groups and insurers agree on coding, coverage, and formulary placement rather than consumer driven subscription uptake alone.
What Explains the Fast Uptake of Digital Insomnia Therapeutics in China?
China records a 24.5% growth rate for digital insomnia therapeutics through 2036, anchored in hospital digitization policy and centralized deployment models. Public hospitals expand mental health and sleep clinics inside digital care frameworks that already support chronic disease management. Once a software product enters a hospital system, distribution reaches large patient volumes at low marginal cost. Urban stress related sleep disorders increase visit counts per patient. Provincial health platforms favor tools that standardize follow up and data capture. Revenue growth follows system level rollouts across city networks rather than individual clinic sales cycles.
Why Is India Becoming a High Velocity Market for Digital Insomnia Solutions?
India advances at a 23% annual rate in digital insomnia therapeutics through 2036 due to a shortage of trained sleep specialists and rising demand for scalable care models. Urban clinics and telemedicine platforms use software to extend limited clinical capacity across large patient pools. Smartphone access and low delivery cost support rapid onboarding. Employers adopt sleep programs as part of mental wellness coverage. Hospitals use digital tools for follow up rather than for first diagnosis. Growth speed reflects service access gaps and the economic advantage of software based care in high volume outpatient environments.
What Structural Factors Support Digital Insomnia Adoption in Germany?
Germany shows a 20% growth rate for digital insomnia therapeutics through 2036, supported by formal recognition of prescribed digital therapies inside the healthcare system. Physicians can integrate approved software into routine treatment plans under regulated reimbursement frameworks. Patients accept digital tools when they appear as part of standard care rather than optional aids. Hospital outpatient departments and sickness funds influence product selection. Uptake depends on evidence packages and compliance review rather than marketing reach. The expansion pace reflects the speed at which new products pass regulatory review and enter reimbursed treatment pathways.
How Does the French Healthcare System Shape Digital Insomnia Demand?
France records a 17% annual increase in digital insomnia therapeutics through 2036, driven by public health system adoption and structured mental health programs. Sleep disorders receive growing attention inside primary care and psychiatry networks. Digital tools support follow up and therapy continuity across long waiting lists. National reimbursement decisions influence scale more than individual provider choice. Hospitals and regional health agencies control deployment across large populations. Growth depends on integration into approved care protocols and public funding frameworks, which creates steady but measured expansion across the national system.
What Limits and Supports Digital Insomnia Growth in the United Kingdom?
The United Kingdom shows a 15.5% growth rate for digital insomnia therapeutics through 2036, shaped by NHS commissioning structures and capacity management goals. Digital tools reduce pressure on overstretched sleep and mental health services. Adoption occurs through pilot programs that later expand across regional trusts. Evidence standards and budget impact reviews govern purchasing decisions. Patients receive access through referral pathways rather than direct purchase. Growth remains controlled since procurement cycles move slowly, while long term demand stays firm due to persistent waiting lists and workforce constraints.
Why Is Brazil Emerging as a Developing Digital Insomnia Market?
Brazil advances at a 14% annual rate in digital insomnia therapeutics through 2036, supported by private healthcare networks and employer funded health programs. Access to sleep specialists remains uneven across regions, which increases reliance on digital follow up tools. Large hospital groups use software to standardize care across multi city networks. Consumer self pay plays a role, yet institutional contracts drive volume. Economic variability limits rapid nationwide rollout. Growth reflects gradual penetration into private insurance systems and corporate health programs rather than universal public sector deployment.
Why Digital Insomnia Therapy Is Becoming a Care Pathway Component Rather Than a Standalone App?
-market-analysis-by-company.webp)
As per Fact.MR observations, the digital insomnia therapy market is being shaped by payer integration and chronic care management models rather than by consumer app adoption cycles. Employers, insurers, and health systems now define sleep treatment as part of structured behavioural care pathways, which fixes demand before product comparison begins. Big Health benefits from clinical positioning and outcomes based programmes that fit into reimbursed digital therapy frameworks. Teladoc and ResMed gain leverage through broader virtual care and sleep health ecosystems, where insomnia modules are embedded into multi condition management flows. Happify participates where mental wellbeing programmes are bundled into population health contracts. Purchasing decisions are driven by evidence standards, engagement persistence, and interoperability with care management platforms rather than by interface design. Once a digital therapy is written into a benefit structure, switching becomes complex because reporting, outcomes tracking, and provider workflows are affected. In this structure, competitive advantage sits with platforms that own referral pathways and long term engagement rather than with those offering isolated sleep tools. This frames Fact.MR’s long term outlook for the segment.
Key Players in Digital Insomnia (DTx) Market
- Big Health Ltd.
- Teladoc Health, Inc.
- Happify Health, Inc.
- ResMed Inc.
- Others
Scope of the Report
| Items | Values |
|---|---|
| Quantitative Units (2026) | USD million |
| DTx Product Types | CBT-I digital therapeutics (prescription or regulated), CBT-I consumer apps (non-prescription), sleep coaching and tele-psychology bundles, comorbidity modules (anxiety, pain, menopause), data integrations and outcomes reporting |
| Use Cases | Chronic insomnia disorder treatment, insomnia with anxiety or depression overlap, insomnia in cardiometabolic patients, shift-work or occupational insomnia, post-acute or post-COVID sleep support |
| End User or Channel | Payers or employers (benefit programs), provider-prescribed DTx channel, direct-to-consumer subscriptions, telehealth platforms, others |
| Regions Covered | Asia Pacific, Europe, North America, Latin America, Middle East & Africa |
| Countries Covered | United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, South Korea, India, Australia & New Zealand, ASEAN, Brazil, Chile, Saudi Arabia, Turkey, South Africa, and other regional markets |
| Key Companies Profiled | Big Health Ltd., Teladoc Health, Inc., Happify Health, Inc., ResMed Inc. |
| Additional Attributes | Dollar by sales by product type, use case, and channel; focus on payer and employer adoption, outcomes tracking, and care pathway integration; demand driven by chronic insomnia management, benefit inclusion, and scalable digital delivery |
Digital Insomnia (DTx) Market Segmentation
-
DTx Product Types :
- CBT-I Digital Therapeutics (Prescription / Regulated)
- CBT-I Consumer Apps (Non-Prescription)
- Sleep Coaching & Tele-Psychology Bundles
- Comorbidity Modules (Anxiety, Pain, Menopause)
- Data Integrations & Outcomes Reporting
-
Use Cases :
- Chronic Insomnia Disorder Treatment
- Insomnia with Anxiety/Depression Overlap
- Insomnia in Cardiometabolic Patients
- Shift-Work or Occupational Insomnia
- Post-Acute or Post-COVID Sleep Support
-
End User or Channel :
- Payers or Employers (Benefit Programs)
- Provider-Prescribed DTx Channel
- Direct-to-Consumer Subscriptions
- Telehealth Platforms
- Others
-
Region :
- Asia Pacific
- China
- Japan
- South Korea
- India
- Australia & New Zealand
- ASEAN
- Rest of Asia Pacific
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- BENELUX
- Rest of Europe
- North America
- United States
- Canada
- Mexico
- Latin America
- Brazil
- Chile
- Rest of Latin America
- Middle East & Africa
- Kingdom of Saudi Arabia
- Other GCC Countries
- Turkey
- South Africa
- Other African Union
- Rest of Middle East & Africa
- Asia Pacific
References
- U.S. Food and Drug Administration. (2024). Digital health technologies for remote data acquisition in clinical investigations: Guidance for industry. FDA.
- National Institute for Health and Care Excellence. (2024). Evidence standards framework for digital health technologies (Updated version). NICE, United Kingdom.
- Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM). (2024). DiGA directory and fast-track process for digital health applications. German Federal Institute for Drugs and Medical Devices.
- American Academy of Sleep Medicine. (2023). Digital cognitive behavioral therapy for insomnia: Summary and context. AASM professional guidance page.
Table of Content
- Executive Summary
- Global Market Outlook
- Demand to side Trends
- Supply to side Trends
- Technology Roadmap Analysis
- Analysis and Recommendations
- Market Overview
- Market Coverage / Taxonomy
- Market Definition / Scope / Limitations
- Research Methodology
- Chapter Orientation
- Analytical Lens and Working Hypotheses
- Market Structure, Signals, and Trend Drivers
- Benchmarking and Cross-market Comparability
- Market Sizing, Forecasting, and Opportunity Mapping
- Research Design and Evidence Framework
- Desk Research Programme (Secondary Evidence)
- Company Annual and Sustainability Reports
- Peer-reviewed Journals and Academic Literature
- Corporate Websites, Product Literature, and Technical Notes
- Earnings Decks and Investor Briefings
- Statutory Filings and Regulatory Disclosures
- Technical White Papers and Standards Notes
- Trade Journals, Industry Magazines, and Analyst Briefs
- Conference Proceedings, Webinars, and Seminar Materials
- Government Statistics Portals and Public Data Releases
- Press Releases and Reputable Media Coverage
- Specialist Newsletters and Curated Briefings
- Sector Databases and Reference Repositories
- FMR Internal Proprietary Databases and Historical Market Datasets
- Subscription Datasets and Paid Sources
- Social Channels, Communities, and Digital Listening Inputs
- Additional Desk Sources
- Expert Input and Fieldwork (Primary Evidence)
- Primary Modes
- Qualitative Interviews and Expert Elicitation
- Quantitative Surveys and Structured Data Capture
- Blended A8oach
- Why Primary Evidence is Used
- Field Techniques
- Interviews
- Surveys
- Focus Groups
- Observational and In-context Research
- Social and Community Interactions
- Stakeholder Universe Engaged
- C-suite Leaders
- Board Members
- Presidents and Vice Presidents
- R&D and Innovation Heads
- Technical Specialists
- Domain Subject-matter Experts
- Scientists
- Physicians and Other Healthcare Professionals
- Governance, Ethics, and Data Stewardship
- Research Ethics
- Data Integrity and Handling
- Primary Modes
- Tooling, Models, and Reference Databases
- Desk Research Programme (Secondary Evidence)
- Data Engineering and Model Build
- Data Acquisition and Ingestion
- Cleaning, Normalisation, and Verification
- Synthesis, Triangulation, and Analysis
- Quality Assurance and Audit Trail
- Market Background
- Market Dynamics
- Drivers
- Restraints
- Opportunity
- Trends
- Scenario Forecast
- Demand in Optimistic Scenario
- Demand in Likely Scenario
- Demand in Conservative Scenario
- Opportunity Map Analysis
- Product Life Cycle Analysis
- Supply Chain Analysis
- Investment Feasibility Matrix
- Value Chain Analysis
- PESTLE and Porter’s Analysis
- Regulatory Landscape
- Regional Parent Market Outlook
- Production and Consumption Statistics
- Import and Export Statistics
- Market Dynamics
- Global Market Analysis 2021 to 2025 and Forecast, 2026 to 2036
- Historical Market Size Value (USD Million) Analysis, 2021 to 2025
- Current and Future Market Size Value (USD Million) Projections, 2026 to 2036
- Y to o to Y Growth Trend Analysis
- Absolute $ Opportunity Analysis
- Global Market Pricing Analysis 2021 to 2025 and Forecast 2026 to 2036
- Global Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By DTx Product Types
- Introduction / Key Findings
- Historical Market Size Value (USD Million) Analysis By DTx Product Types, 2021 to 2025
- Current and Future Market Size Value (USD Million) Analysis and Forecast By DTx Product Types, 2026 to 2036
- CBT-I Digital Therapeutics (Prescription / Regulated)
- CBT-I Consumer Apps (Non-Prescription)
- Sleep Coaching & Tele-Psychology Bundles
- Comorbidity Modules (Anxiety, Pain, Menopause)
- Data Integrations & Outcomes Reporting
- CBT-I Digital Therapeutics (Prescription / Regulated)
- Y to o to Y Growth Trend Analysis By DTx Product Types, 2021 to 2025
- Absolute $ Opportunity Analysis By DTx Product Types, 2026 to 2036
- Global Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Use Cases
- Introduction / Key Findings
- Historical Market Size Value (USD Million) Analysis By Use Cases, 2021 to 2025
- Current and Future Market Size Value (USD Million) Analysis and Forecast By Use Cases, 2026 to 2036
- Chronic Insomnia Disorder Treatment
- Insomnia with Anxiety/Depression Overlap
- Insomnia in Cardiometabolic Patients
- Shift-Work or Occupational Insomnia
- Post-Acute or Post-COVID Sleep Support
- Chronic Insomnia Disorder Treatment
- Y to o to Y Growth Trend Analysis By Use Cases, 2021 to 2025
- Absolute $ Opportunity Analysis By Use Cases, 2026 to 2036
- Global Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By End User or Channel
- Introduction / Key Findings
- Historical Market Size Value (USD Million) Analysis By End User or Channel, 2021 to 2025
- Current and Future Market Size Value (USD Million) Analysis and Forecast By End User or Channel, 2026 to 2036
- Payers or Employers (Benefit Programs)
- Provider-Prescribed DTx Channel
- Direct-to-Consumer Subscriptions
- Telehealth Platforms
- Others
- Payers or Employers (Benefit Programs)
- Y to o to Y Growth Trend Analysis By End User or Channel, 2021 to 2025
- Absolute $ Opportunity Analysis By End User or Channel, 2026 to 2036
- Global Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Region
- Introduction
- Historical Market Size Value (USD Million) Analysis By Region, 2021 to 2025
- Current Market Size Value (USD Million) Analysis and Forecast By Region, 2026 to 2036
- North America
- Latin America
- Western Europe
- Eastern Europe
- East Asia
- South Asia and Pacific
- Middle East & Africa
- Market Attractiveness Analysis By Region
- North America Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Country
- Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
- Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
- By Country
- USA
- Canada
- Mexico
- By DTx Product Types
- By Use Cases
- By End User or Channel
- By Country
- Market Attractiveness Analysis
- By Country
- By DTx Product Types
- By Use Cases
- By End User or Channel
- Key Takeaways
- Latin America Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Country
- Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
- Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
- By Country
- Brazil
- Chile
- Rest of Latin America
- By DTx Product Types
- By Use Cases
- By End User or Channel
- By Country
- Market Attractiveness Analysis
- By Country
- By DTx Product Types
- By Use Cases
- By End User or Channel
- Key Takeaways
- Western Europe Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Country
- Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
- Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
- By Country
- Germany
- UK
- Italy
- Spain
- France
- Nordic
- BENELUX
- Rest of Western Europe
- By DTx Product Types
- By Use Cases
- By End User or Channel
- By Country
- Market Attractiveness Analysis
- By Country
- By DTx Product Types
- By Use Cases
- By End User or Channel
- Key Takeaways
- Eastern Europe Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Country
- Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
- Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
- By Country
- Russia
- Poland
- Hungary
- Balkan & Baltic
- Rest of Eastern Europe
- By DTx Product Types
- By Use Cases
- By End User or Channel
- By Country
- Market Attractiveness Analysis
- By Country
- By DTx Product Types
- By Use Cases
- By End User or Channel
- Key Takeaways
- East Asia Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Country
- Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
- Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
- By Country
- China
- Japan
- South Korea
- By DTx Product Types
- By Use Cases
- By End User or Channel
- By Country
- Market Attractiveness Analysis
- By Country
- By DTx Product Types
- By Use Cases
- By End User or Channel
- Key Takeaways
- South Asia and Pacific Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Country
- Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
- Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
- By Country
- India
- ASEAN
- Australia & New Zealand
- Rest of South Asia and Pacific
- By DTx Product Types
- By Use Cases
- By End User or Channel
- By Country
- Market Attractiveness Analysis
- By Country
- By DTx Product Types
- By Use Cases
- By End User or Channel
- Key Takeaways
- Middle East & Africa Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Country
- Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
- Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
- By Country
- Kingdom of Saudi Arabia
- Other GCC Countries
- Turkiye
- South Africa
- Other African Union
- Rest of Middle East & Africa
- By DTx Product Types
- By Use Cases
- By End User or Channel
- By Country
- Market Attractiveness Analysis
- By Country
- By DTx Product Types
- By Use Cases
- By End User or Channel
- Key Takeaways
- Key Countries Market Analysis
- USA
- Pricing Analysis
- Market Share Analysis, 2025
- By DTx Product Types
- By Use Cases
- By End User or Channel
- Canada
- Pricing Analysis
- Market Share Analysis, 2025
- By DTx Product Types
- By Use Cases
- By End User or Channel
- Mexico
- Pricing Analysis
- Market Share Analysis, 2025
- By DTx Product Types
- By Use Cases
- By End User or Channel
- Brazil
- Pricing Analysis
- Market Share Analysis, 2025
- By DTx Product Types
- By Use Cases
- By End User or Channel
- Chile
- Pricing Analysis
- Market Share Analysis, 2025
- By DTx Product Types
- By Use Cases
- By End User or Channel
- Germany
- Pricing Analysis
- Market Share Analysis, 2025
- By DTx Product Types
- By Use Cases
- By End User or Channel
- UK
- Pricing Analysis
- Market Share Analysis, 2025
- By DTx Product Types
- By Use Cases
- By End User or Channel
- Italy
- Pricing Analysis
- Market Share Analysis, 2025
- By DTx Product Types
- By Use Cases
- By End User or Channel
- Spain
- Pricing Analysis
- Market Share Analysis, 2025
- By DTx Product Types
- By Use Cases
- By End User or Channel
- France
- Pricing Analysis
- Market Share Analysis, 2025
- By DTx Product Types
- By Use Cases
- By End User or Channel
- India
- Pricing Analysis
- Market Share Analysis, 2025
- By DTx Product Types
- By Use Cases
- By End User or Channel
- ASEAN
- Pricing Analysis
- Market Share Analysis, 2025
- By DTx Product Types
- By Use Cases
- By End User or Channel
- Australia & New Zealand
- Pricing Analysis
- Market Share Analysis, 2025
- By DTx Product Types
- By Use Cases
- By End User or Channel
- China
- Pricing Analysis
- Market Share Analysis, 2025
- By DTx Product Types
- By Use Cases
- By End User or Channel
- Japan
- Pricing Analysis
- Market Share Analysis, 2025
- By DTx Product Types
- By Use Cases
- By End User or Channel
- South Korea
- Pricing Analysis
- Market Share Analysis, 2025
- By DTx Product Types
- By Use Cases
- By End User or Channel
- Russia
- Pricing Analysis
- Market Share Analysis, 2025
- By DTx Product Types
- By Use Cases
- By End User or Channel
- Poland
- Pricing Analysis
- Market Share Analysis, 2025
- By DTx Product Types
- By Use Cases
- By End User or Channel
- Hungary
- Pricing Analysis
- Market Share Analysis, 2025
- By DTx Product Types
- By Use Cases
- By End User or Channel
- Kingdom of Saudi Arabia
- Pricing Analysis
- Market Share Analysis, 2025
- By DTx Product Types
- By Use Cases
- By End User or Channel
- Turkiye
- Pricing Analysis
- Market Share Analysis, 2025
- By DTx Product Types
- By Use Cases
- By End User or Channel
- South Africa
- Pricing Analysis
- Market Share Analysis, 2025
- By DTx Product Types
- By Use Cases
- By End User or Channel
- USA
- Market Structure Analysis
- Competition Dashboard
- Competition Benchmarking
- Market Share Analysis of Top Players
- By Regional
- By DTx Product Types
- By Use Cases
- By End User or Channel
- Competition Analysis
- Competition Deep Dive
- Big Health Ltd.
- Overview
- Product Portfolio
- Profitability by Market Segments (Product/Age /Sales Channel/Region)
- Sales Footprint
- Strategy Overview
- Marketing Strategy
- Product Strategy
- Channel Strategy
- Teladoc Health, Inc.
- Happify Health, Inc.
- ResMed Inc.
- Others
- Big Health Ltd.
- Competition Deep Dive
- Assumptions & Acronyms Used
List Of Table
- Table 1: Global Market Value (USD Million) Forecast by Region, 2021 to 2036
- Table 2: Global Market Value (USD Million) Forecast by DTx Product Types, 2021 to 2036
- Table 3: Global Market Value (USD Million) Forecast by Use Cases, 2021 to 2036
- Table 4: Global Market Value (USD Million) Forecast by End User or Channel, 2021 to 2036
- Table 5: North America Market Value (USD Million) Forecast by Country, 2021 to 2036
- Table 6: North America Market Value (USD Million) Forecast by DTx Product Types, 2021 to 2036
- Table 7: North America Market Value (USD Million) Forecast by Use Cases, 2021 to 2036
- Table 8: North America Market Value (USD Million) Forecast by End User or Channel, 2021 to 2036
- Table 9: Latin America Market Value (USD Million) Forecast by Country, 2021 to 2036
- Table 10: Latin America Market Value (USD Million) Forecast by DTx Product Types, 2021 to 2036
- Table 11: Latin America Market Value (USD Million) Forecast by Use Cases, 2021 to 2036
- Table 12: Latin America Market Value (USD Million) Forecast by End User or Channel, 2021 to 2036
- Table 13: Western Europe Market Value (USD Million) Forecast by Country, 2021 to 2036
- Table 14: Western Europe Market Value (USD Million) Forecast by DTx Product Types, 2021 to 2036
- Table 15: Western Europe Market Value (USD Million) Forecast by Use Cases, 2021 to 2036
- Table 16: Western Europe Market Value (USD Million) Forecast by End User or Channel, 2021 to 2036
- Table 17: Eastern Europe Market Value (USD Million) Forecast by Country, 2021 to 2036
- Table 18: Eastern Europe Market Value (USD Million) Forecast by DTx Product Types, 2021 to 2036
- Table 19: Eastern Europe Market Value (USD Million) Forecast by Use Cases, 2021 to 2036
- Table 20: Eastern Europe Market Value (USD Million) Forecast by End User or Channel, 2021 to 2036
- Table 21: East Asia Market Value (USD Million) Forecast by Country, 2021 to 2036
- Table 22: East Asia Market Value (USD Million) Forecast by DTx Product Types, 2021 to 2036
- Table 23: East Asia Market Value (USD Million) Forecast by Use Cases, 2021 to 2036
- Table 24: East Asia Market Value (USD Million) Forecast by End User or Channel, 2021 to 2036
- Table 25: South Asia and Pacific Market Value (USD Million) Forecast by Country, 2021 to 2036
- Table 26: South Asia and Pacific Market Value (USD Million) Forecast by DTx Product Types, 2021 to 2036
- Table 27: South Asia and Pacific Market Value (USD Million) Forecast by Use Cases, 2021 to 2036
- Table 28: South Asia and Pacific Market Value (USD Million) Forecast by End User or Channel, 2021 to 2036
- Table 29: Middle East & Africa Market Value (USD Million) Forecast by Country, 2021 to 2036
- Table 30: Middle East & Africa Market Value (USD Million) Forecast by DTx Product Types, 2021 to 2036
- Table 31: Middle East & Africa Market Value (USD Million) Forecast by Use Cases, 2021 to 2036
- Table 32: Middle East & Africa Market Value (USD Million) Forecast by End User or Channel, 2021 to 2036
List Of Figures
- Figure 1: Global Market Pricing Analysis
- Figure 2: Global Market Value (USD Million) Forecast 2021 to 2036
- Figure 3: Global Market Value Share and BPS Analysis by DTx Product Types, 2026 and 2036
- Figure 4: Global Market Y to o to Y Growth Comparison by DTx Product Types, 2026 to 2036
- Figure 5: Global Market Attractiveness Analysis by DTx Product Types
- Figure 6: Global Market Value Share and BPS Analysis by Use Cases, 2026 and 2036
- Figure 7: Global Market Y to o to Y Growth Comparison by Use Cases, 2026 to 2036
- Figure 8: Global Market Attractiveness Analysis by Use Cases
- Figure 9: Global Market Value Share and BPS Analysis by End User or Channel, 2026 and 2036
- Figure 10: Global Market Y to o to Y Growth Comparison by End User or Channel, 2026 to 2036
- Figure 11: Global Market Attractiveness Analysis by End User or Channel
- Figure 12: Global Market Value (USD Million) Share and BPS Analysis by Region, 2026 and 2036
- Figure 13: Global Market Y to o to Y Growth Comparison by Region, 2026 to 2036
- Figure 14: Global Market Attractiveness Analysis by Region
- Figure 15: North America Market Incremental Dollar Opportunity, 2026 to 2036
- Figure 16: Latin America Market Incremental Dollar Opportunity, 2026 to 2036
- Figure 17: Western Europe Market Incremental Dollar Opportunity, 2026 to 2036
- Figure 18: Eastern Europe Market Incremental Dollar Opportunity, 2026 to 2036
- Figure 19: East Asia Market Incremental Dollar Opportunity, 2026 to 2036
- Figure 20: South Asia and Pacific Market Incremental Dollar Opportunity, 2026 to 2036
- Figure 21: Middle East & Africa Market Incremental Dollar Opportunity, 2026 to 2036
- Figure 22: North America Market Value Share and BPS Analysis by Country, 2026 and 2036
- Figure 23: North America Market Value Share and BPS Analysis by DTx Product Types, 2026 and 2036
- Figure 24: North America Market Y to o to Y Growth Comparison by DTx Product Types, 2026 to 2036
- Figure 25: North America Market Attractiveness Analysis by DTx Product Types
- Figure 26: North America Market Value Share and BPS Analysis by Use Cases, 2026 and 2036
- Figure 27: North America Market Y to o to Y Growth Comparison by Use Cases, 2026 to 2036
- Figure 28: North America Market Attractiveness Analysis by Use Cases
- Figure 29: North America Market Value Share and BPS Analysis by End User or Channel, 2026 and 2036
- Figure 30: North America Market Y to o to Y Growth Comparison by End User or Channel, 2026 to 2036
- Figure 31: North America Market Attractiveness Analysis by End User or Channel
- Figure 32: Latin America Market Value Share and BPS Analysis by Country, 2026 and 2036
- Figure 33: Latin America Market Value Share and BPS Analysis by DTx Product Types, 2026 and 2036
- Figure 34: Latin America Market Y to o to Y Growth Comparison by DTx Product Types, 2026 to 2036
- Figure 35: Latin America Market Attractiveness Analysis by DTx Product Types
- Figure 36: Latin America Market Value Share and BPS Analysis by Use Cases, 2026 and 2036
- Figure 37: Latin America Market Y to o to Y Growth Comparison by Use Cases, 2026 to 2036
- Figure 38: Latin America Market Attractiveness Analysis by Use Cases
- Figure 39: Latin America Market Value Share and BPS Analysis by End User or Channel, 2026 and 2036
- Figure 40: Latin America Market Y to o to Y Growth Comparison by End User or Channel, 2026 to 2036
- Figure 41: Latin America Market Attractiveness Analysis by End User or Channel
- Figure 42: Western Europe Market Value Share and BPS Analysis by Country, 2026 and 2036
- Figure 43: Western Europe Market Value Share and BPS Analysis by DTx Product Types, 2026 and 2036
- Figure 44: Western Europe Market Y to o to Y Growth Comparison by DTx Product Types, 2026 to 2036
- Figure 45: Western Europe Market Attractiveness Analysis by DTx Product Types
- Figure 46: Western Europe Market Value Share and BPS Analysis by Use Cases, 2026 and 2036
- Figure 47: Western Europe Market Y to o to Y Growth Comparison by Use Cases, 2026 to 2036
- Figure 48: Western Europe Market Attractiveness Analysis by Use Cases
- Figure 49: Western Europe Market Value Share and BPS Analysis by End User or Channel, 2026 and 2036
- Figure 50: Western Europe Market Y to o to Y Growth Comparison by End User or Channel, 2026 to 2036
- Figure 51: Western Europe Market Attractiveness Analysis by End User or Channel
- Figure 52: Eastern Europe Market Value Share and BPS Analysis by Country, 2026 and 2036
- Figure 53: Eastern Europe Market Value Share and BPS Analysis by DTx Product Types, 2026 and 2036
- Figure 54: Eastern Europe Market Y to o to Y Growth Comparison by DTx Product Types, 2026 to 2036
- Figure 55: Eastern Europe Market Attractiveness Analysis by DTx Product Types
- Figure 56: Eastern Europe Market Value Share and BPS Analysis by Use Cases, 2026 and 2036
- Figure 57: Eastern Europe Market Y to o to Y Growth Comparison by Use Cases, 2026 to 2036
- Figure 58: Eastern Europe Market Attractiveness Analysis by Use Cases
- Figure 59: Eastern Europe Market Value Share and BPS Analysis by End User or Channel, 2026 and 2036
- Figure 60: Eastern Europe Market Y to o to Y Growth Comparison by End User or Channel, 2026 to 2036
- Figure 61: Eastern Europe Market Attractiveness Analysis by End User or Channel
- Figure 62: East Asia Market Value Share and BPS Analysis by Country, 2026 and 2036
- Figure 63: East Asia Market Value Share and BPS Analysis by DTx Product Types, 2026 and 2036
- Figure 64: East Asia Market Y to o to Y Growth Comparison by DTx Product Types, 2026 to 2036
- Figure 65: East Asia Market Attractiveness Analysis by DTx Product Types
- Figure 66: East Asia Market Value Share and BPS Analysis by Use Cases, 2026 and 2036
- Figure 67: East Asia Market Y to o to Y Growth Comparison by Use Cases, 2026 to 2036
- Figure 68: East Asia Market Attractiveness Analysis by Use Cases
- Figure 69: East Asia Market Value Share and BPS Analysis by End User or Channel, 2026 and 2036
- Figure 70: East Asia Market Y to o to Y Growth Comparison by End User or Channel, 2026 to 2036
- Figure 71: East Asia Market Attractiveness Analysis by End User or Channel
- Figure 72: South Asia and Pacific Market Value Share and BPS Analysis by Country, 2026 and 2036
- Figure 73: South Asia and Pacific Market Value Share and BPS Analysis by DTx Product Types, 2026 and 2036
- Figure 74: South Asia and Pacific Market Y to o to Y Growth Comparison by DTx Product Types, 2026 to 2036
- Figure 75: South Asia and Pacific Market Attractiveness Analysis by DTx Product Types
- Figure 76: South Asia and Pacific Market Value Share and BPS Analysis by Use Cases, 2026 and 2036
- Figure 77: South Asia and Pacific Market Y to o to Y Growth Comparison by Use Cases, 2026 to 2036
- Figure 78: South Asia and Pacific Market Attractiveness Analysis by Use Cases
- Figure 79: South Asia and Pacific Market Value Share and BPS Analysis by End User or Channel, 2026 and 2036
- Figure 80: South Asia and Pacific Market Y to o to Y Growth Comparison by End User or Channel, 2026 to 2036
- Figure 81: South Asia and Pacific Market Attractiveness Analysis by End User or Channel
- Figure 82: Middle East & Africa Market Value Share and BPS Analysis by Country, 2026 and 2036
- Figure 83: Middle East & Africa Market Value Share and BPS Analysis by DTx Product Types, 2026 and 2036
- Figure 84: Middle East & Africa Market Y to o to Y Growth Comparison by DTx Product Types, 2026 to 2036
- Figure 85: Middle East & Africa Market Attractiveness Analysis by DTx Product Types
- Figure 86: Middle East & Africa Market Value Share and BPS Analysis by Use Cases, 2026 and 2036
- Figure 87: Middle East & Africa Market Y to o to Y Growth Comparison by Use Cases, 2026 to 2036
- Figure 88: Middle East & Africa Market Attractiveness Analysis by Use Cases
- Figure 89: Middle East & Africa Market Value Share and BPS Analysis by End User or Channel, 2026 and 2036
- Figure 90: Middle East & Africa Market Y to o to Y Growth Comparison by End User or Channel, 2026 to 2036
- Figure 91: Middle East & Africa Market Attractiveness Analysis by End User or Channel
- Figure 92: Global Market - Tier Structure Analysis
- Figure 93: Global Market - Company Share Analysis
- FAQs -
How big is the digital insomnia (dtx) market in 2026?
The global digital insomnia (dtx) market is estimated to be valued at USD 513.0 million in 2026.
What will be the size of digital insomnia (dtx) market in 2036?
The market size for the digital insomnia (dtx) market is projected to reach USD 3,747.3 million by 2036.
How much will be the digital insomnia (dtx) market growth between 2026 and 2036?
The digital insomnia (dtx) market is expected to grow at a 22.0% CAGR between 2026 and 2036.
What are the key product types in the digital insomnia (dtx) market?
The key product types in digital insomnia (dtx) market are cbt-i digital therapeutics (prescription / regulated), cbt-i consumer apps (non-prescription), sleep coaching & tele-psychology bundles, comorbidity modules (anxiety, pain, menopause) and data integrations & outcomes reporting.
Which use cases segment to contribute significant share in the digital insomnia (dtx) market in 2026?
In terms of use cases, chronic insomnia disorder treatment segment to command 58.0% share in the digital insomnia (dtx) market in 2026.